BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29995747)

  • 1. Bazedoxifene-Conjugated Estrogens for Treating Endometriosis.
    Flores VA; Stachenfeld NS; Taylor HS
    Obstet Gynecol; 2018 Aug; 132(2):475-477. PubMed ID: 29995747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
    Lewiecki EM
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A
    J Am Assoc Nurse Pract; 2013 Mar; 25(3):126-33. PubMed ID: 24218199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA; Pinkerton JV; Gass MLS; Dorin MH; Ronkin S; Pickar JH; Constantine G
    Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
    Stovall DW
    Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
    Archer DF; Lewis V; Carr BR; Olivier S; Pickar JH
    Fertil Steril; 2009 Sep; 92(3):1039-1044. PubMed ID: 19635614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.
    Rossini M; Lello S; Sblendorio I; Viapiana O; Fracassi E; Adami S; Gatti D
    Drug Des Devel Ther; 2013; 7():601-10. PubMed ID: 23901263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
    Pickar JH; Yeh IT; Bachmann G; Speroff L
    Fertil Steril; 2009 Sep; 92(3):1018-1024. PubMed ID: 19635613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated estrogens/bazedoxifene (Duavee) for menopausal symptoms and prevention of osteoporosis.
    Med Lett Drugs Ther; 2014 Apr; 56(1441):33-4. PubMed ID: 24759293
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS; Mirkin S; Jenkins SN
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-selective Estrogen Complex for Menopausal Hormone Therapy.
    Pinkerton JV
    Clin Obstet Gynecol; 2018 Sep; 61(3):463-469. PubMed ID: 29851863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
    Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
    Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S; Ryan KA; Chandran AB; Komm BS
    Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Mirkin S; Pinkerton JV; Kagan R; Thompson JR; Pan K; Pickar JH; Komm BS; Archer DF
    J Womens Health (Larchmt); 2016 May; 25(5):431-42. PubMed ID: 27058301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
    Mirkin S; Komm B; Pickar JH
    Womens Health (Lond); 2014 Mar; 10(2):135-46. PubMed ID: 24601804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.